DA

Darrell R. Anderson

BI Biogen Idec: 14 patents #2 of 60Top 4%
IP Idec Pharmaceuticals: 5 patents #7 of 30Top 25%
Overall (All Time): #198,048 of 4,157,543Top 5%
22
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
7744877 Expression and use of anti-CD20 Antibodies Nabil Hanna, John Leonard, Roland A. Newman, Mitchell E. Reff, William H. Rastetter 2010-06-29
7510712 Methods of treating rheumatoid arthritis with 7C10 and 16C10 CD80-specific antibodies Nabil Hanna, Peter Brams 2009-03-31
7510713 Methods of inducing immunosuppression by administering 7C10 and 16C10 CD80-specific antibodies Nabil Hanna, Peter Brams 2009-03-31
7501264 Methods of producing 7C10 and 16C10 CD80-specific antibodies Nabil Hanna, Peter Brams 2009-03-10
7491393 Methods of inhibiting IL-2 production by T cells by administering 7C10 and 16C10 CD80-specific antibodies Nabil Hanna, Peter Brams 2009-02-17
7425447 Host cells expressing 7C10 and 16C10 CD80-specific antibodies Nabil Hanna, Peter Brams 2008-09-16
7422739 Anti-CD20 antibodies Nabil Hanna, Roland A. Newman, Mitchell E. Reff, William H. Rastetter 2008-09-09
7417128 7C10 and 16C10 CD80-specific antibodies Nabil Hanna, Peter Brams 2008-08-26
7414123 Nucleic acids encoding 7C10 and 16C10 CD80-specific antibodies Nabil Hanna, Peter Brams 2008-08-19
7381560 Expression and use of anti-CD20 antibodies Nabil Hanna, Roland A. Newman, Mitchell E. Reff, William H. Rastetter 2008-06-03
7323170 Anti-CD80 antibodies Peter Brams, Nabil Hanna, William S. Shestowsky, Cheryl Heard 2008-01-29
7192585 CD80 specific antibodies Nabil Hanna, Peter Brams 2007-03-20
7175847 Treating intestinal inflammation with anti-CD80 antibodies that do not inhibit CD80 binding to CTLA-4 Nabil Hanna, Peter Brams 2007-02-13
7153508 Treatment of B cell lymphoma using anti-CD80 antibodies that do not inhibit the binding of CD80 to CTLA-4 Nabil Hanna, Peter Brams 2006-12-26
6893638 Methods for treating b cell lymphoma using CD80-specific antibodies Peter Brams, Nabil Hanna, William S. Shestowsky, Cheryl Heard 2005-05-17
6709654 Treatment of psoriasis using anti-B7.1 (CD80) antibodies Peter Brams, Nabil Hanna, William S. Shestowsky, Cheryl Heard 2004-03-23
6682734 Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma Nabil Hanna, John Leonard, Roland A. Newman, Mitchell E. Reff, William H. Rastetter 2004-01-27
6399061 Chimeric and radiolabelled antibodies specific to human CD20 antigen and use thereof for treatment of B-cell lymphoma Nabil Hanna, Roland A. Newman, Mitchell E. Reff, William H. Rastetter 2002-06-04
6113898 Human B7.1-specific primatized antibodies and transfectomas expressing said antibodies Peter Brams, Nabil Hanna, William S. Shestowsky, Cheryl Heard 2000-09-05
5843439 Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma Nabil Hanna, John Leonard, Roland A. Newman, Mitchell E. Reff, William H. Rastetter 1998-12-01
5776456 Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma Nabil Hanna, John Leonard, Roland A. Newman, Mitchell E. Reff, William H. Rastetter 1998-07-07
5736137 Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma Nabil Hanna, John Leonard, Roland A. Newman, Mitchell E. Reff, William H. Rastetter 1998-04-07